Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 27

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

MicroRNA‑223 attenuates LPS‑induced inflammation in an acute lung injury model via the NLRP3 inflammasome and TLR4/NF‑κB signaling pathway via RHOB

Yan, Yurong, Lu, Kexin, Ye, Ting, Zhang, Zongwang · 2019 · International Journal of Molecular Medicine

Abstract

Acute lung injury (ALI) and the more severe acute respiratory distress syndrome are common and complex inflammatory lung diseases. MicroRNAs (miRs) have emerged as novel gene regulatory molecules, serving a crucial role in a variety of complex diseases, including ALI. In the present study, the anti‑inflammatory action of miR‑223 on inflammation in ALI was demonstrated and the possible mechanism was further examined. In lipopolysaccharide‑induced ALI, the expression of miR‑223 was reduced compared with that in the control normal group. An in vitro model was used to analyze the effect of miR‑223 downregulation on an ALI model, which increased inflammation, and induced the activation of the NACHT, LRR and PYD domains‑containing protein 3 (NLRP3) inflammasome and Toll‑like receptor 4 (TLR4)/nuclear factor (NF)‑κB signaling pathway via rho‑related GTP‑binding protein RhoB (RHOB). In addition, the overexpression of miR‑223 reduced inflammation and suppressed the NLRP3 inflammasome and TLR4/NF‑κB signaling pathway via RHOB in the in vitro model. Furthermore, TLR4 inhibitor or NLRP3 inhibitor reduced the pro‑inflammatory effect of miR‑223 downregulation in ALI. In conclusion, the results of the present study indicated that miR‑223 functioned as a biological indicator by regulating inflammation in ALI, and may represent a novel potential therapeutic target and prognostic marker of ALI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ijmm.2019.4075

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 miR-223 expression in ALI mice. (A) Hematoxylin and eosin staining of lung tissue. (B) TNF-α, (C) IL-1β, (D) IL-6 and (E) IL-18 were assayed. (F) Gene chip and (G) reverse transcription-quantitative polymerase chain reaction analysis for miR-223 expression in ALI mice. Scale bar, 100 µm. **P<0.01 vs. control. ALI, acute lung injury; miR, microRNA; IL, interleukin; TNF-α, tumor necrosis factor-α.
Figure 1 miR-223 expression in ALI mice. (A) Hematoxylin and eosin staining of lung tissue. (B) TNF-α, (C) IL-1β, (D) IL-6 and (E) IL-18 were assayed. (F) Gene chip and (G) reverse transcription-quantitative polymerase chain reaction analysis for miR-223 expression in ALI mice. Scale bar, 100 µm. **P<0.01 vs. control. ALI, acute lung injury; miR, microRNA; IL, interleukin; TNF-α, tumor necrosis factor-α.CC BY-NC-ND · PubMed Central
Figure 2 miR-223 expression in ALI in vitro. (A) IL-1β, (B) IL-18, (C) miR-223 expression was assessed in vitro in the ALI model induced by LPS. miR-223 expression in cells transfected with (D) miR-233 and (E) anti-miR-223. IL-1β expression in cells transfected with (F) miR-233 and (H) anti-miR-223. IL-18 expression in cells transfected with (G) miR-233 and (I) anti-miR-223. **P<0.01 vs. respective control. ALI, acute lung injury; miR, microRNA; LPS, lipopoly-saccharide; IL, interleukin.
Figure 2 miR-223 expression in ALI in vitro. (A) IL-1β, (B) IL-18, (C) miR-223 expression was assessed in vitro in the ALI model induced by LPS. miR-223 expression in cells transfected with (D) miR-233 and (E) anti-miR-223. IL-1β expression in cells transfected with (F) miR-233 and (H) anti-miR-223. IL-18 expression in cells transfected with (G) miR-233 and (I) anti-miR-223. **P<0.01 vs. respective control. ALI, acute lung injury; miR, microRNA; LPS, lipopoly-saccharide; IL, interleukin.CC BY-NC-ND · PubMed Central
Figure 3 miR-223 regulates NLRP3 protein expression in acute lung injury in vitro. (A) Gene chip assay of the signaling pathway. (B) NLRP3, (C) TLR4 and (D) NF-κB mRNA expression. (E) Predicted miR-223 binding sites in the NLRP3 3′-UTR. (F) Dual-luciferase reporter gene assay. (G) Immunofluorescence for NLRP3 protein expression. Magnification, ×200. **P<0.01 vs. respective control. UTR, untranslated region; NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, Toll-like receptor 4; NF-κB, nuclear factor-κB; WT, wild type; MUT, mutant.
Figure 3 miR-223 regulates NLRP3 protein expression in acute lung injury in vitro. (A) Gene chip assay of the signaling pathway. (B) NLRP3, (C) TLR4 and (D) NF-κB mRNA expression. (E) Predicted miR-223 binding sites in the NLRP3 3′-UTR. (F) Dual-luciferase reporter gene assay. (G) Immunofluorescence for NLRP3 protein expression. Magnification, ×200. **P<0.01 vs. respective control. UTR, untranslated region; NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, Toll-like receptor 4; NF-κB, nuclear factor-κB; WT, wild type; MUT, mutant.CC BY-NC-ND · PubMed Central
Figure 4 miR-223 regulates the TLR4 and NLRP3 signaling pathway in acute lung injury in vitro. (A) NLRP3 and (B) caspase-1 protein expression was quantified following downregulation of miR-223. (C) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB. (D) TLR4 and (E) NF-κB protein expression was quantified following downregulation of miR-223. (F) NLRP3 and (G) caspase-1 protein expression was quantified following upregulation of miR-223. (H) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB. (I) TLR4 and (J) NF-κB protein expression was quantified following upregulation of miR-223. **P<0.01 vs. negative control. NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB.
Figure 4 miR-223 regulates the TLR4 and NLRP3 signaling pathway in acute lung injury in vitro. (A) NLRP3 and (B) caspase-1 protein expression was quantified following downregulation of miR-223. (C) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB. (D) TLR4 and (E) NF-κB protein expression was quantified following downregulation of miR-223. (F) NLRP3 and (G) caspase-1 protein expression was quantified following upregulation of miR-223. (H) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB. (I) TLR4 and (J) NF-κB protein expression was quantified following upregulation of miR-223. **P<0.01 vs. negative control. NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB.CC BY-NC-ND · PubMed Central
Figure 5 Inhibition of TLR4 reduces the pro-inflammatory effect of anti-miR-223 on inflammation in acute lung injury in vitro. (A) NLRP3, (B) caspase-1, (C) TLR4 and (D) NF-κB protein expression was quantified. (E) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB protein expression. (F) IL-1β and (G) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. anti-223 group. TLR4 i, TLR4 inhibitor and anti-miR-233 combined; NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; IL, interleukin.
Figure 5 Inhibition of TLR4 reduces the pro-inflammatory effect of anti-miR-223 on inflammation in acute lung injury in vitro. (A) NLRP3, (B) caspase-1, (C) TLR4 and (D) NF-κB protein expression was quantified. (E) Western blot analysis of NLRP3, caspase-1, TLR4 and NF-κB protein expression. (F) IL-1β and (G) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. anti-223 group. TLR4 i, TLR4 inhibitor and anti-miR-233 combined; NLRP3, NACHT, LRR and PYD domains-containing protein 3; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; IL, interleukin.CC BY-NC-ND · PubMed Central
Figure 6 Inhibition of NLRP3 reduces the pro-inflammatory effect of anti-miR-223 on inflammation in acute lung injury in vitro. (A) NLRP3 and (B) caspase-1 protein expression was quantified. (C) Western blot analysis of NLRP3 and caspase-1 protein expression. (D) IL-1β and (E) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. anti-223 group. NLRP3, NACHT, LRR and PYD domains-containing protein 3; NLRP3 i, NLRP3 inhibitor and anti-miR-233 combined; miR, microRNA; IL, interleukin.
Figure 6 Inhibition of NLRP3 reduces the pro-inflammatory effect of anti-miR-223 on inflammation in acute lung injury in vitro. (A) NLRP3 and (B) caspase-1 protein expression was quantified. (C) Western blot analysis of NLRP3 and caspase-1 protein expression. (D) IL-1β and (E) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. anti-223 group. NLRP3, NACHT, LRR and PYD domains-containing protein 3; NLRP3 i, NLRP3 inhibitor and anti-miR-233 combined; miR, microRNA; IL, interleukin.CC BY-NC-ND · PubMed Central
Figure 7 miR-223 regulates the TLR4 signaling pathway in acute lung injury in vitro via RHOB. (A) Predicted miR-223 binding sites in the RHOB 3′-untranslated region. (B) Dual-luciferase reporter gene assay. RHOB protein expression was quantified in cells with (C) miR-223 upregulation and (D) miR-223 downregulation. Western blot analysis of RHOB protein expression in cells with (E) miR-223 upregulation and (F) miR-223 downregulation. (G) RHOB, (H) TLR4 and (I) NF-κB protein expression was quantified. (J) Western blot analysis of RHOB, TLR4 and NF-κB. (K) IL1β and (L) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. miR-223 group. RHOB, rho-related GTP-binding protein RhoB; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; IL, interleukin.
Figure 7 miR-223 regulates the TLR4 signaling pathway in acute lung injury in vitro via RHOB. (A) Predicted miR-223 binding sites in the RHOB 3′-untranslated region. (B) Dual-luciferase reporter gene assay. RHOB protein expression was quantified in cells with (C) miR-223 upregulation and (D) miR-223 downregulation. Western blot analysis of RHOB protein expression in cells with (E) miR-223 upregulation and (F) miR-223 downregulation. (G) RHOB, (H) TLR4 and (I) NF-κB protein expression was quantified. (J) Western blot analysis of RHOB, TLR4 and NF-κB. (K) IL1β and (L) IL-18 were analyzed. **P<0.01 vs. negative control; ##P<0.01 vs. miR-223 group. RHOB, rho-related GTP-binding protein RhoB; miR, microRNA; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; IL, interleukin.CC BY-NC-ND · PubMed Central
Figure 8 Activation of RHOB reduces the effects of miR-223 on inflammation in acute lung injury in vitro. (A) miR-223, (B) TLR4, (C) NF-κB, (D) RHOB, (E) NLRP3 and (F) caspase-1 protein expression was quantified. (G) Western blot analysis. **P<0.01 vs. control group; ##P<0.01 vs. negative control; &&P<0.01 vs. miR-223 group; ++P<0.01 vs. RhoB group. miR, microRNA; RHOB, rho-related GTP-binding protein RhoB, rho-related GTP-binding protein RhoB; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; NLRP3, NACHT, LRR and PYD domains-containing protein 3.
Figure 8 Activation of RHOB reduces the effects of miR-223 on inflammation in acute lung injury in vitro. (A) miR-223, (B) TLR4, (C) NF-κB, (D) RHOB, (E) NLRP3 and (F) caspase-1 protein expression was quantified. (G) Western blot analysis. **P<0.01 vs. control group; ##P<0.01 vs. negative control; &&P<0.01 vs. miR-223 group; ++P<0.01 vs. RhoB group. miR, microRNA; RHOB, rho-related GTP-binding protein RhoB, rho-related GTP-binding protein RhoB; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; NLRP3, NACHT, LRR and PYD domains-containing protein 3.CC BY-NC-ND · PubMed Central
Figure 9 MicroRNA-223 attenuates LPS-induced inflammation in acute lung injury model via the NLRP3 inflammasome. LPS, lipopolysaccharide; RHOB, rho-related GTP-binding protein RhoB; TLR4, Toll-like receptor 4; NF-κB, nuclear factor-κB; NLRP3, NACHT, LRR and PYD domains-containing protein 3; IL, interleukin; ASC, PYD and CARD domain containing.
Figure 9 MicroRNA-223 attenuates LPS-induced inflammation in acute lung injury model via the NLRP3 inflammasome. LPS, lipopolysaccharide; RHOB, rho-related GTP-binding protein RhoB; TLR4, Toll-like receptor 4; NF-κB, nuclear factor-κB; NLRP3, NACHT, LRR and PYD domains-containing protein 3; IL, interleukin; ASC, PYD and CARD domain containing.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 27

Metadata

Authors
Yan, Y., Lu, K., Ye, T., & Zhang, Z.
Affiliations
  • Shandong University, Jinan, Shandong 250012, P.R. China
  • Department of Obstetrics, Binzhou Medical University Hospital, Binzhou, Shandong 256600, P.R. China
  • Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, Shandong 256600, P.R. China
  • Department of Anesthesiology, Liaocheng People's Hospital, Liaocheng, Shandong 252000, P.R. China
Venue
International Journal of Molecular Medicine
Published
2019-01-23
ISSN
  • 1107-3756
  • 1791-244X
Cited by
27
References
26

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.